Rapamycin Plus Methylprednisolone Versus Methylprednisolone Alone in Active, Moderate-to-severe Graves' Orbitopathy.
Clinical trial NCT05532072 · UNKNOWN
Trial details
- NCT number
- NCT05532072
- Sponsor
- First Affiliated Hospital Xi'an Jiaotong University
- Status
- UNKNOWN
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-01
- Primary completion
- 2023-09-01
- Enrollment
- 140
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.